Lipid Levels and Short-Term Risk of Recurrent Brain Infarcts in Symptomatic Intracranial Stenosis

Area of Science:

• Neurology
• Cardiovascular Medicine
• Medical Imaging

Background:

• Hyperlipidemia is a significant risk factor for intracranial atherosclerotic disease (ICAD) and subsequent clinical stroke recurrence.
• Understanding the impact of serum lipid levels on subclinical infarct recurrence is crucial for managing ICAD patients.

Purpose of the Study:

• To investigate the association between baseline serum lipid levels and the occurrence of subclinical infarct recurrence in patients with symptomatic ICAD.
• To identify specific lipid markers that predict early infarct recurrence within the MYRIAD study cohort.

Main Methods:

• The study analyzed data from 74 patients in the MYRIAD study with available lipid measurements and brain MRI at baseline and 6-8 weeks.
• Infarct recurrence was determined by comparing baseline and follow-up MRIs for new infarcts in the symptomatic artery's territory.
• Multivariable logistic regression was used to assess the relationship between baseline total cholesterol (TC), LDL-C, HDL-C, triglycerides (TG), and recurrent infarcts.

Main Results:

• Twenty-seven percent of patients experienced new or recurrent infarcts.
• Patients with recurrent infarcts had lower mean HDL-C and higher mean TG levels.
• Elevated LDL-C (adjusted OR 1.022) and TG (adjusted OR 1.009) were identified as significant predictors of infarct recurrence at 6-8 weeks, even after adjusting for other factors.

Conclusions:

• Baseline serum lipid profiles, particularly LDL-C and TG levels, can predict early infarct recurrence in patients with symptomatic ICAD.
• The findings suggest that more aggressive and prompt lipid-lowering interventions may be necessary to mitigate the risk of early stroke recurrence in this patient population.